These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8236946)

  • 21. [A noninjection method of using live measles vaccine].
    Liashenko VA; Iuminova NV; Krasnova VP
    Vopr Virusol; 1996; 41(2):84-6. PubMed ID: 8686283
    [No Abstract]   [Full Text] [Related]  

  • 22. A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.
    Chabot S; Brewer A; Lowell G; Plante M; Cyr S; Burt DS; Ward BJ
    Vaccine; 2005 Feb; 23(11):1374-83. PubMed ID: 15661386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National Advisory Committee on Immunization (NACI). Interim advisory on measles revaccination of persons with acquired immunodeficiency syndrome (AIDS).
    Can Commun Dis Rep; 1996 Jul; 22(14):116-7. PubMed ID: 8754936
    [No Abstract]   [Full Text] [Related]  

  • 24. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
    Wong-Chew RM; Beeler JA; Audet S; Santos JI
    J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on the persistence of immunity 15 years after revaccination with measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):392-5. PubMed ID: 2598096
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
    Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
    Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles revaccination response in a school-age population.
    Wittler RR; Veit BC; McIntyre S; Schydlower M
    Pediatrics; 1991 Nov; 88(5):1024-30. PubMed ID: 1945606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Persistence of immunity to attenuated measles live vaccine. V. Persistence of immunity after primary immunization with 4 strains of live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1983 Aug; 63(8):490-2. PubMed ID: 6418341
    [No Abstract]   [Full Text] [Related]  

  • 31. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles revaccination.
    Med Lett Drugs Ther; 1989 Jul; 31(797):69-70. PubMed ID: 2747586
    [No Abstract]   [Full Text] [Related]  

  • 33. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 34. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Duration of immunity and occurrence of secondary vaccine failure following vaccination against measles, mumps and rubella].
    Trier H; Rønne T
    Ugeskr Laeger; 1992 Jul; 154(29):2008-13. PubMed ID: 1509566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Basis for the need for mass revaccination against measles and results of conducting it].
    Rykushin IuP; Deshevoĭ SE
    Tr Inst Im Pastera; 1992; 67():96-102. PubMed ID: 8539773
    [No Abstract]   [Full Text] [Related]  

  • 37. [The cell-mediated response after measles vaccination].
    Pala S; Crimaldi G; Consolini R; Macchia P
    Pediatr Med Chir; 1998; 20(3):213-6. PubMed ID: 9744016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Need for measles revaccination.
    John TJ
    Indian Pediatr; 1998 Aug; 35(8):789-91. PubMed ID: 10216577
    [No Abstract]   [Full Text] [Related]  

  • 39. Antimeasles vaccination by natural routes--experimental background and practical consequences.
    Cernescu C; Cajal N
    Virologie; 1984; 35(4):259-71. PubMed ID: 6083659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Revaccination against measles].
    Gerike E; Kirchner W; Pöhle W; Tischer A
    Z Gesamte Hyg; 1983 Feb; 29(2):62-5. PubMed ID: 6858258
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.